{
  "id": "cluster_2_doc4",
  "content": "Policy update CM-8871 now requires pre-authorization genetic testing for all patients entering immunotherapy protocols. This applies specifically to Silver Pine Clinic and two other research facilities. Implementation began October 15 with a 30-day grace period.",
  "metadata": {
    "format": "policy_document"
  }
}